SYMPHONIE - A comparison of Symbicort Single inhaler and conventional best practice for the treatment of persistent asthma in adolescents and adults

Study identifier:D5890L00005

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A comparison of Symbicort Single inhaler and conventional best practice for the treatment of persistent asthma in adolescents and adults – a 26-week, randomised, open, parallel group multicentre study

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

No

Study drug

-

Sex

All

Actual enrollment

1000

Study type

Interventional

Age

12 Years +

Date

Study Start Date: 01 Sept 2004
Primary Completion Date: -
Study Completion Date: 01 Jan 2006

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria